Form 8-K - Current report:
SEC Accession No. 0001140361-23-009759
Filing Date
2023-03-02
Accepted
2023-03-02 16:32:30
Documents
13
Period of Report
2023-03-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10048946_8k.htm   iXBRL 8-K 28170
2 EXHIBIT 99.1 brhc10048946_ex99-1.htm EX-99.1 158682
  Complete submission text file 0001140361-23-009759.txt   337729

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA siga-20230302.xsd EX-101.SCH 3853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE siga-20230302_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE siga-20230302_pre.xml EX-101.PRE 16036
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10048946_8k_htm.xml XML 4052
Mailing Address 31 EAST 62ND STREET NEW YORK NY 10065
Business Address 31 EAST 62ND STREET NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Filer) CIK: 0001010086 (see all company filings)

IRS No.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38436 | Film No.: 23699557
SIC: 2834 Pharmaceutical Preparations